A pH-responsive drug release system based on doxorubicin conjugated amphiphilic polymer coated quantum dots for tumor cell targeting and tracking

Journal of Chemical Technology and Biotechnology

Volumn 88, Issue 12, 2013, Pages 2169-2175

  Yang, Bohan ^a   Li, Yapeng ^a   Sun, Xiaoran ^a   Meng, Xinlei ^a   Chen, Peng ^a   Liu, Nian ^b  

^a JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Applied Biochemistry; Pharmaceuticals; Synthesis; Toxicity

Indexed keywords

AMPHIPHILIC POLYMERS; CLINICAL APPLICATION; DRUG RELEASE SYSTEM; FIRST ORDER KINETICS; INTRACELLULAR LOCALIZATION; RECEPTOR-MEDIATED ENDOCYTOSIS; TARGETING MOLECULES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR;

CELL ENGINEERING; DRUG PRODUCTS; ENDOTHELIAL CELLS; MOLECULAR BIOLOGY; NANOPARTICLES; POLYETHYLENE GLYCOLS; SEMICONDUCTOR QUANTUM DOTS; SYNTHESIS (CHEMICAL); TOXICITY; TUMORS;

CONJUGATED POLYMERS;

AMPHOPHILE; DODECYLAMINE; DOXORUBICIN; ITACONIC ACID; MACROGOL; NANOCOMPOSITE; POLYMER; QUANTUM DOT; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER CELL; CELL TRACKING; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOTOXICITY; DRUG CONJUGATION; DRUG RELEASE; ENDOCYTOSIS; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; LIVER CANCER; MOLECULAR PROBE; NANOENCAPSULATION; PARTICLE SIZE; PH; PROTEIN EXPRESSION;

EID: 84887048432     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.4081     Document Type: Article

References (45)

1. Laurent S, Forge D, Port M, Roch A, Robic C, L. Vander Elst and Muller RN, Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations and biological applications. Chem Rev 108:2064-2110 (2008).
2. Wu X, He X, Zhong L, Lin S, Wang D, Zhu X and Yan D, Water-soluble dendritic-linear triblock copolymer-modified magnetic nanoparticles: preparation, characterization and drug release properties. J Mater Chem 21:13611-13620 (2011).
3. Gijs MAM, Lacharme FDR and Lehmann U, Microfluidic applications of magnetic particles for biological analysis and catalysis. Chem Rev 110:1518-1563 (2010).
4. Frey NA, Peng S, Cheng K and Sun S, Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev 38:2532-2542 (2009).
5. Huang H, Remsen EE, Kowalewski T and Wooley KL, Nanocages derived from shell cross-linked micelle templates. J Am Chem Soc 121:3805 (1999).
6. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V and Langer R, Biodegradable long-circulating polymeric nanospheres. Science 263:1600 (1994).
7. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP and Langer R, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Nat Acad Sci USA 103:6315 (2006).
8. Lee H, Lee E, Kim DK, Jang NK, Jeong YY and Jon S, Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 128:7383 (2006).
9. Yang J, Lee T, Lee J, Lim EK, Hyung W, Lee CH, Song YJ, Suh JS, Yoon HG, Huh YM and Haam S, Synthesis of ultrasensitive magnetic resonance contrast agents for cancer imaging using PEG-fatty acid. Chem Mater 19:3870-3876 (2007).
10. Laginha KM, Verwoert S, Charrois GJR and Allen TM, Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 11:6944-6949 (2005).
11. Aryal S, Grailer JJ, Steeberband S and Gong S, Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers. J Mater Chem 19:7879-7884 (2009).
12. Frederick CA, Williams LD, Ughetto G, van der Marel GA, van Boom JH, Rich A and Wang AHJ, Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry 29:2538-2549 (1990).
13. Etrych T, Jelinkova M, Rihova B and Ulbrich K, New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. J Controlled Release 73:89-102 (2001).
14. Weiss AJ and Manthel RW, Experience with the use of Adriamycin in a combination with other anticancer agents using a weekly schedule with particular reference to lack of cardiac toxicity. Cancer 40:2046-2052 (1977).
15. Nasongkla N, Bey E and Ren J, Multifunctional polymeric micelles as cancer-targeted, mri-ultrasensitive drug delivery systems. Nano Lett 6:2427-2430 (2006).
16. Kohler N, Sun C and Fichtenholtz A, Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2:785-792 (2006).
17. Jaiswal JK, Goldman ER, Mattoussi H and Simon SM, Use of quantum dots for live cell imaging. Nat Methods 1:73-78 (2004).
18. Murray CB, Norris DJ and Bawendi MG, Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am Chem Soc 115:8706-8715 (1993).
19. Yu WW, Wang YA and Peng X, Formation and stability of size-, shape-, and structure-controlled CdTe nanocrystals: ligand effects on monomers and nanocrystal. Chem Mater 15:4300-4308 (2003).
20. Yu WW and Peng X, Formation of high-quality CdS and other II-VI semiconductor nanocrystals in noncoordinating solvents: tunable reactivity of monomers. Angew Chem 41:2368-2371 (2002).
21. Li JJ, Wang YA, Guo W, Keay JC, Mishima TD, Johnson MB and Peng X, Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. J Am Chem Soc 125:12567-12575 (2003).
22. Talapin DV, Rogach AL, Kornowski A, Haase M and Weller H, Highly luminescent monodisperse CdSe and CdSe/ZnS nanocrystals synthesized in a hexadecylamine-trioctylphosphine oxide-trioctylphospine mixture. Nano Lett 1:207-211 (2001).
23. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH and Libchaber A, In Vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298:1759-1762 (2002).
24. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F and Bruchez MP, Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 21:41-46 (2002).
25. Pellegrino T, Manna L, Kudera S, Liedl T, Koktysh D, Rogach AL, Keller S, Raedler J, Natile G and Parak WJ, hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett 4:703-707(2004).
26. Willke T and Vorlop KD, Biotechnological production of itaconic acid. Appl Microbiol Biotechnol 56:289-295 (2001).
27. Lanthong P, Nuisin R and Kiatkamjornwong S, Graft copolymerization, characterization, and degradation of cassava starch-g-acrylamide/itaconic acid superabsorbent. Carbohyd Polym 66:229-245 (2006).
28. Dickey JB and Coover HW, Coplymers containing 9-methylenefluorene. US Patent 2, 533, 207 (1950).
29. Pitzl G, Vinylidene chloride interpolymer as a coating for regenerated cellulose film. US Patent 2, 570, 478 (1951).
30. D'Alelio GF, Interpolymers of acrylonitrile and itaconic acid. US Patent 2, 531, 408 (Nov. 28, 1950).
31. Marvel CS and Shepherd TH, Polymerization reactions of itaconic acid and some of Its derivatives. J Org Chem 24:599-605 (1959).
32. Mrkvan T, Sirova M, Etrych T, Chyti Pl, Strohalm J, Plocova D, Ulbrich K and Rihova B, Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity. J Control Release 110:119-129 (2005).
33. Pechar M, Braunova A, Ulbrich K, Jelinkova M and Rihova B, Poly(ethylene glycol) - doxorubicin conjugates with pH-controlled activation. J Bioact Compat Polym 20:319-341 (2005).
34. Rodrigues P, Fiebig T, Unger C, Mulhaupt R and Kratz F, Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity. Bioorg Med Chem 14:4110-4117 (2006).
35. Ulbrich K and Subr V, Polymeric anticancer drugs with pH-controlled activation. Adv Drug Delivery Rev 56:1023-1050 (2004).
36. Weissleder R, Lee AS, Fischman AJ, Reimer P, Shen T, Wilkinson R, Callahan RJ and Brady TJ, Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology 181: 245-249 (1991).
37. Bulte J and Kraitchman DL, Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499 (2004).
38. Elcin YM, Dixit V and Gitnick T, Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs 25:558-565 (2001).
39. Chandra S, Mehta S, Nigam S and Bahadur D, Dendritic magnetite nanocarriers for drug delivery application. New J Chem 34:648-655 (2010).
40. Higuchi Y, Kawakami S and Hashida M, Strategies for in vivo delivery of siRNAs: recent progress. Bio Drugs 24:195-205 (2010).
41. Kawakami S, Higuchi Y and Hashida M, Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J Pharm Sci 97:726-745 (2008).
42. Mulye NV and Turco SJ, A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dehydrate matrices. Drug Dev Ind Pharm 21:943-953(1995).
43. Higuchi T, Rate of release of medicaments from ointment bases containing drugs in suspensions. J Pharm Sci 50:874-875 (1961).
44. Korsmeyer RW, Gurny R and Doelker EM, Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 15:25-35 (1983).
45. Peppas NA and Khare R, Preparation, structure and diffusion behavior of hydrogels in controlled released. Adv Drug Delivery Rev 11:1-35(1993).